Flow Cytometric Characterization of Murine B Cell Development.

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Murine B cell development and differentiation are extensively studied in secondary lymphoid organs.
• Antibodies produced by B cells are key components of established therapeutics.
• Understanding B cell development is critical for evaluating immunomodulatory drugs and antibody-based therapies.

Purpose of the Study:

• To outline best practices for using flow cytometry to assess murine B cell development.
• To highlight the importance of flow cytometry in validating therapeutic agents in preclinical models.
• To emphasize the complementary nature of flow cytometry with other B cell assessment methods.

Main Methods:

• Utilizing established B cell flow cytometric parameters to analyze B cell populations.
• Evaluating B cell development across multiple murine compartments: peritoneum, bone marrow, and spleen.
• Integrating flow cytometric data with additional immunological readouts.

Main Results:

• Established flow cytometric parameters effectively characterize B cell development in murine models.
• Adherence to specific best practices is crucial for reliable and reproducible results.
• Flow cytometry provides valuable insights into B cell dynamics in wild-type, autoimmune-prone, and humanized mice.

Conclusions:

• Flow cytometry is a validated and critical tool for assessing B cell development in mice.
• Standardized flow cytometric analysis supports the preclinical development of antibody therapeutics.
• This methodology enhances the understanding of B cell biology in diverse mouse models relevant to human diseases and therapy.